D.2.d Applicability of Class J&A (Redacted).pdf

This document provides details of a contract modification to contract number 75D30121C10297 awarded by the Centers for Disease Control and Prevention to The Children's Hospital Corporation. The modification was issued on February 4, 2022 in the amount of $994,000 under authority of FAR 6.302-2, Unusual and Compelling Urgency, in response to the ongoing COVID-19 pandemic.

The purpose of the modification is to support enrollment of up to an additional 1,000 case and control patients for COVID-19 vaccine effectiveness evaluations among hospitalized children aged 5-11, a critical and timely objective. Services required under the modification and original contract include continuing to build a network to study COVID-19 and MIS-C in hospitalized children across multiple US sites, updating a study database, contributing to a biospecimen repository, describing clinical manifestations and exposures, and identifying risk factors for severe outcomes.